Quantapore

About:

Quantapore is a biotech company developing nanopore-based nucleic acid sequencing technology.

Top Investors: Foothill Ventures, Northern Light Venture Capital, Fusion Fund, Baidu Ventures, Sangel Capital

Description:

Quantapore is a biotech company developing nanopore-based nucleic acid sequencing technology. Unlike other nanopore approaches, Quantapore utilizes an optical read out which results in lower cost and higher throughput compared to electrical data acquisition. Its novel proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost. Quantapore was founded by Sascha C. Dennstedt and Martin Huber in 2009.

Total Funding Amount:

$52M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2009-01-01

Founders:

Martin Huber, Sascha C. Dennstedt

Number of Employees:

1-10

Last Funding Date:

2018-07-19

IPO Status:

Private

Industries: